Perineural and lymphovascular invasion in squamous cell carcinoma of the tongue.


Journal

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
ISSN: 1600-0714
Titre abrégé: J Oral Pathol Med
Pays: Denmark
ID NLM: 8911934

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 22 07 2020
revised: 30 07 2020
accepted: 03 08 2020
pubmed: 21 8 2020
medline: 24 2 2021
entrez: 21 8 2020
Statut: ppublish

Résumé

Perineural invasion (PNI) and lymphovascular invasion (LVI) may be adverse prognostic indicators in squamous cell carcinoma (SCC) of the tongue. The percentages of histological PNI and LVI were determined in 335 patients with tongue SCC. Sixty tumours originally reported as negative for these features were tested to determine how many more were positive with "immunohistochemical enhancement." PNI was found in 141 (42.1%) and LVI in 51 (15.2%) patients. 79.4% of the 141 patients who had PNI and 72.6% of the 51 with LVI had a T3 or T4 tumour. Lymph node metastasis was identified in 145 (51.2%) of the 280 patients who had undergone neck dissection; 58.2% of the 141 patients with PNI and 80.4% of the 51 patients with LVI had lymph node metastasis. There was a highly statistically significant correlation between PNI with increasing pT (P < .00001) and pN (P < .0001) stage, and a statistically significant correlation between LVI and pT stage (P < .001), the association of LVI with pN status could not be reliably tested statistically. Immunohistochemistry for S100 identified five further cases of PNI, but review of the original H&E showed the feature was present in four and had been missed at original reporting. CD31 identified three further possible cases of LVI and D2-40 none. The endothelium of some vascular channels was positive for both CD31 and D2-40 and cross-reactivity with other cells compromised interpretation. Histological identification of PNI and LVI per se remains of uncertain prognostic significance. "Immunohistochemical enhancement" offered little benefit.

Sections du résumé

BACKGROUND BACKGROUND
Perineural invasion (PNI) and lymphovascular invasion (LVI) may be adverse prognostic indicators in squamous cell carcinoma (SCC) of the tongue.
METHODS METHODS
The percentages of histological PNI and LVI were determined in 335 patients with tongue SCC. Sixty tumours originally reported as negative for these features were tested to determine how many more were positive with "immunohistochemical enhancement."
RESULTS RESULTS
PNI was found in 141 (42.1%) and LVI in 51 (15.2%) patients. 79.4% of the 141 patients who had PNI and 72.6% of the 51 with LVI had a T3 or T4 tumour. Lymph node metastasis was identified in 145 (51.2%) of the 280 patients who had undergone neck dissection; 58.2% of the 141 patients with PNI and 80.4% of the 51 patients with LVI had lymph node metastasis. There was a highly statistically significant correlation between PNI with increasing pT (P < .00001) and pN (P < .0001) stage, and a statistically significant correlation between LVI and pT stage (P < .001), the association of LVI with pN status could not be reliably tested statistically. Immunohistochemistry for S100 identified five further cases of PNI, but review of the original H&E showed the feature was present in four and had been missed at original reporting. CD31 identified three further possible cases of LVI and D2-40 none. The endothelium of some vascular channels was positive for both CD31 and D2-40 and cross-reactivity with other cells compromised interpretation.
CONCLUSIONS CONCLUSIONS
Histological identification of PNI and LVI per se remains of uncertain prognostic significance. "Immunohistochemical enhancement" offered little benefit.

Identifiants

pubmed: 32815232
doi: 10.1111/jop.13104
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-38

Subventions

Organisme : Queen Victoria Hospital NHS Foundation Trusts' charitable fund

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Helliwell T, Woolgar JA.Dataset for histopathology reporting of mucosal malignancies of the oral cavity. Royal College of Pathologists, November 2013. Unique document number G110. http://www.rcpath.org/publications-media/publications/datasets/datasets-TP.htm. Accessed September 5, 2020.
Brown B, Barnes L, Mazariegos J, Taylor F, Johnson J, Wagner RL. Prognostic factors in mobile tongue and floor of mouth carcinoma. Cancer. 1989;64:1195-1202.
Fagan JJ, Collins B, Barnes L, D’Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:637-640.
Yuen APW, Lam KY, Lam LK, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma. A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck. 2002;24:513-520.
Sparano A, Weinstein G, Chalian A, Yodul M, Weber R. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg. 2004;131:472-476.
D’Cruz AK, Siddachari RC, Walvekar RR, et al. Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue. Head Neck. 2009;31:618-624.
Brandwein-Gensler M, Smith RV, Wang B, et al. Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol. 2010;34:676-688.
Kurtz KA, Hoffman HT, Zimmerman MB, Robinson RA. Perineural and vascular invasion in oral cavity squamous carcinoma. Increased incidence on re-review of slides and by using immunohistochemical enhancement. Arch Pathol Lab Med. 2005;129:354-359.
Shen W-R, Wang Y-P, Chang JYF, Yu SY, Chen H-M, Chiang C-P. Perineural invasion and expression of nerve growth factor can predict the progression and prognosis of oral tongue squamous cell carcinoma. J Oral Pathol Med. 2014;43:258-264.
Jardim JF, Francisco ALF, Gondak R, Damascena A, Kowalski LP. Prognostic impact of perineural invasion and lymphovascular invasion in advanced stage oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2015;44:23-28.
Matsushita Y, Yanamoto S, Takahashi H, et al. A clinicopathological study of perineural invasion and lymphovascular invasion in oral tongue squamous cell carcinoma. Int J Oral Maxillofac Surg. 2015;44:543-548.
McMahon JD, Pitts R, Isbister J, et al. Postoperative risk stratification in oral squamous cell carcinoma. Brit J Oral Maxillofac Surg. 2020;58:462-468.
Tai SK, Li WY, Chu PY, et al. Risks and clinical implications of perineural invasion in T1-2 oral tongue squamous cell carcinoma. Head Neck. 2012;34:994-1001.
Liao CT, Chang JT, Wang HM, et al. Does adjuvant radiation therapy improve outcomes in pT1-3 N0 oral cavity cancer with tumor-free margins and perineural invasion? Int J Radiat Oncol Biol Phys. 2008;71:371-376.
Chen TC, Wang CP, Ko JY, et al. The impact of perineural invasion and/or lymphovascular invasion on the survival of early-stage oral squamous cell carcinoma patients. Ann Surg Oncol. 2013;20:2388-2395.
Aivasian K, Ebrahimi A, Low T-H, et al. Perineural invasion in oral squamous cell carcinoma: quantitative subcategorisation of perineural invasion and prognostication. J Surg Oncol. 2015;111:352-358.
Michikawa C, Uzawa N, Kayamori K, et al. Clinical significance of lymphatic and blood vessel invasion in oral tongue squamous cell carcinomas. Oral Oncol. 2012;48:320-324.
Nair S, Singh B, Pawar PV, et al. Squamous cell carcinoma of tongue and buccal mucosa: clinico-pathologically different entities. Eur Arch Otorhinolaryngol. 2016;273:3921-3928.
Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer. A review of the literature. Cancer. 2009;115:3379-3391.
Chi AC, Katabi N, Chen H-S, Cheng YL. Interobserver variation among pathologists in evaluating perineural invasion for oral squamous cell carcinoma. Head Neck Pathol. 2016;10:451-464.
Beggan C, Fives C, O’Leary G, Sheahan P, Heffron CC, Feeley L. Pattern of invasion and lymphovascular invasion in squamous cell carcinoma of the floor of the mouth: an interobserver variability study. Histopathol. 2016;69:914-920.
Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest. 2002;82:1255-1257.
Brierley JD, Gospodarowicz MK, Wittekind C, (Eds-in-Chief). TNM Classification of Malignant Tumours, 8th ed. Chichester: Wiley Blackwell; 2017.
Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006;42:229-239.
Huang SH, Hwang D, Lockwood G, Goldstein DP, O'Sullivan B. Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer. 2009;115:1489-1497.
Batsakis JG. Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol. 1985;94:426-427.
Dunn M, Morgan MB, Beer TW. Perineural invasion: identification, significance, and a standardized definition. Dermatol Surg. 2009;35:214-221.
Gupta P, Migliacci JC, Montero PH, et al. Do we need a different staging system for tongue and gingivobuccal complex squamous cell cancers? Oral Oncol. 2018;78:64-71.
Yeh C-F, Li W-Y, Yang M-H, et al. Neck observation is appropriate in T1-2, cN0 oral squamous cell carcinoma without perineural invasion or lymphovascular invasion. Oral Oncol. 2014;50:857-862.
Odell EW, Jani P, Sherriff M, et al. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer. 1994;74:789-794.

Auteurs

Andrew W Barrett (AW)

Department of Histopathology, Queen Victoria Hospital NHSF Trust, East Grinstead, UK.

Murray K Pratt (MK)

Maxillofacial Unit, Queen Victoria Hospital NHSF Trust, East Grinstead, UK.

Isabel Sassoon (I)

Department of Computer Science, Brunel University London, Uxbridge, UK.

Brian S Bisase (BS)

Maxillofacial Unit, Queen Victoria Hospital NHSF Trust, East Grinstead, UK.

Laurence Newman (L)

Maxillofacial Unit, Queen Victoria Hospital NHSF Trust, East Grinstead, UK.

John V Tighe (JV)

Maxillofacial Unit, Queen Victoria Hospital NHSF Trust, East Grinstead, UK.

Paul M Norris (PM)

Maxillofacial Unit, Queen Victoria Hospital NHSF Trust, East Grinstead, UK.

Jag Dhanda (J)

Maxillofacial Unit, Queen Victoria Hospital NHSF Trust, East Grinstead, UK.

Aakshay Gulati (A)

Maxillofacial Unit, Queen Victoria Hospital NHSF Trust, East Grinstead, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH